课题基金 / 基金详情

Reconstruction of the normal vasculature for the strategy of new cancer therapy.

Reconstruction of the normal vasculature for the strategy of new cancer therapy.
重建正常脉管系统以制定新的癌症治疗策略。
批准号:
24659904
负责人:
EZAKI Taichi
金额:
$1.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

EZAKI Taichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We hypothesized that reconstruction of normal blood vessels in tumors may lead to improvement of hypoxic conditions, contributing to potential improvements in the delivery of anticancer drugs. Tumor cells were injected into the dorsal subcutis of SCID mice. After 2 weeks, the tumor-bearing mice were injected cisplatin intraperitoneally to regress tumors and tumor vessels for the first step. Two weeks later, human ECs or human ES-derived ECs were transplanted into necrotic regions of the tumor to induce normal angiogenesis for the second step. Microscopic observations revealed that the transplanted ECs formed anastomoses with the host mouse vasculature. Blood vessels reconstituted by ECs exhibited the normalization of tumor vasculature, resulting in a significant reduction in the tumor volume. Thus, this model is a useful model for the future development of new cancer therapies by the construction of reliable drug delivery systems and the improvement of hypoxic conditions.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Vasohibin-2の抑制が消化管における自然発症腫瘍に影響を及ぼすか
Vasohibin-2 的抑制是否会影响胃肠道自发性肿瘤?
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [北原秀治, 鈴木康弘, 森島正恵, 吉井明日香, 松居彩, 佐藤靖史, 江崎太一]
通讯作者: 江崎太一
臨床的放射線耐性腫瘍を用いた新たな癌治療モデルの確立
利用临床抗辐射肿瘤建立新的癌症治疗模式
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [北原秀治, 鈴木康弘, 森島正恵, 吉井明日香, 松居彩, 佐藤靖史, 江崎太一, 北原秀治, 北原秀治, 北原秀治]
通讯作者: 北原秀治
Transplanting normal endothelial cells into tumor mass retards the tumor growth by vascular reconstruction and vascular normalization
将正常内皮细胞移植到肿瘤块中通过血管重建和血管正常化延缓肿瘤生长
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Shuji Kitahara, Miwako Nishio, Shunichi Morikawa, Kazuko Nakada, Asuka Yoshii, Kumiko Saeki, Taichi Ezaki]
通讯作者: Taichi Ezaki
DOI: 10.1016/j.ajoms.2013.02.004
发表时间: 2013
期刊: Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
影响因子: --
作者: [Shimizu K, Asakura M, Shinga J, Sato Y, Kitaha Hoshino K, Kaisho T, Schoenberger SP, Ezaki T, Fujii S, Yumiko Momokia]
通讯作者: Yumiko Momokia
18
    Verification of the relationship between fat cells and lymphangiogenesis by using a benign lymphangioma model
    • 批准号:
      19390053
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      EZAKI Taichi
    • 依托单位:
    Morphological and functional characterization of a specific marker for lymphatic vessels.
    • 批准号:
      14207001
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.54万
    • 财政年份:
      2002
    • 负责人:
      EZAKI Taichi
    • 依托单位:
    Mechanisms for the collection of cells by lymphatics
    A morphological and functional study on the development and regeneration of lymphatic vessels.
    • 批准号:
      05670018
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      EZAKI Taichi
    • 依托单位:
    国内基金
    海外基金
    肿瘤血管正常化重塑免疫微环境抗肝细胞癌免疫检查点抑制剂治疗抵抗的临床前研究
    基于“破瘀通络”理论揭示β-榄香烯调控C3orf21-PTEN/Notch 轴诱导肺癌肿瘤血管正常化的机制研究
    • 批准号:
      ZCLMS26H2902
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      蔡鹄
    • 依托单位:
    仿生纳米颗粒介导CNV周围NO梯度的构建及其调控AMD血管正常化的研究
    • 批准号:
      QN25H120008
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      金滢滢
    • 依托单位:
    基于PIM-1/EZH2轴探索益肺散结丸促进NSCLC肿瘤血管正常化增敏 免疫治疗的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      肖志伟
    • 依托单位: